5 Best Medical Stocks Under $10

In this article, we will be looking at the 5 best medical stocks under $10. If you want to see our detailed analysis and outlook of the medical industry, go directly to the 10 Best Medical Stocks Under $10.

5. DBV Technologies S.A. (NASDAQ: DBVT)

Number of Hedge Fund Holders: 7
Stock Price as of July 23rd: $5.36

DBV Technologies S.A. (NASDAQ: DBVT) ranks 5th on the 10 best medical stocks under $10. The biopharmaceutical firm based in France develops immunotherapies for food allergies. DBV Technologies S.A. (NASDAQ: DBVT) makes immunology products such as Viaskin for peanut allergy in children ages 4 to 11, which received FDA Fast Track and Breakthrough Therapy designation in 2015, and Viaskin for cow’s milk protein allergy in patients 2 to 17 years old, which received FDA Fast Track designation in 2016.

On May 4th, Societe Generale analyst Delphine Le Louet upgraded DBV Technologies S.A. (NASDAQ: DBVT) to Hold from Sell with a price target of €11 per share. The stock has gained 29% in the past year and 105% year to date. 

The company has a market cap of $606 million. In the first quarter of 2021, DBV Technologies S.A. (NASDAQ: DBVT) had an EPS of -$0.26, beating estimates by $0.34. In the first quarter, the company’s revenue was $2.94 million, a decrease of 37.7%, but beats revenue estimates by $1.54 million. At the end of the first quarter, DBV Technologies S.A. (NASDAQ: DBVT) had cash of $152.5 million. 

At the end of the first quarter of 2021, 7 hedge funds in the database of Insider Monkey held stakes worth $128 million in DBV Technologies S.A. (NASDAQ: DBVT). Baker Bros. Advisors is the company’s largest shareholder, with 14.6 million shares, worth $77,894,000.